Yi Ren

IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients

Yunfeng Ma, Yi Ren, Caijun Wu et al. · Advances in Clinical and Experimental Medicine · 2017 · 249 citations · Full text

Medicine, Immunology, Oncology +17

Outcomes of anti–PD-(L)1 therapy with or without chemotherapy (chemo) for first-line (1L) treatment of advanced non–small cell lung cancer (NSCLC) with PD-L1 score ≥ 50%: FDA pooled analysis.

Oladimeji Akinboro, Jonathon Vallejo, Erica C. Nakajima et al. · Journal of Clinical Oncology · 2022 · 82 citations

Medicine, Oncology, Pharmacology +13

Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis.

Erica C. Nakajima, Yi Ren, Jonathon Vallejo et al. · Journal of Clinical Oncology · 2022 · 56 citations

Medicine, Immunology, Oncology +17

Development and validation of a scoring system to predict progression to acute‐on‐chronic liver failure in patients with acute exacerbation of chronic hepatitis B

Yi Ren, Lulu Liu, Ying Li et al. · Hepatology Research · 2018 · 17 citations

Medicine, Infectious Diseases, Epidemiology +16

Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection

Ling Yuan, Baimei Zeng, Lulu Liu et al. · World Journal of Gastroenterology · 2019 · 17 citations · Full text

Medicine, Infectious Diseases, Hepatology +16